- Home
- GOSS vs AVNW Comparison
GOSS vs AVNW Comparison
Compare GOSS & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- AVNW
- Stock Information
- Founded
- GOSS 2015
- AVNW 2006
- Country
- GOSS United States
- AVNW United States
- Employees
- GOSS N/A
- AVNW N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- GOSS Health Care
- AVNW Technology
- Exchange
- GOSS Nasdaq
- AVNW Nasdaq
- Market Cap
- GOSS 203.3M
- AVNW 214.0M
- IPO Year
- GOSS 2019
- AVNW 2007
- Fundamental
- Price
- GOSS $1.12
- AVNW $20.90
- Analyst Decision
- GOSS Strong Buy
- AVNW Strong Buy
- Analyst Count
- GOSS 4
- AVNW 5
- Target Price
- GOSS $7.50
- AVNW $37.60
- AVG Volume (30 Days)
- GOSS 1.6M
- AVNW 96.3K
- Earning Date
- GOSS 05-13-2025
- AVNW 05-06-2025
- Dividend Yield
- GOSS N/A
- AVNW N/A
- EPS Growth
- GOSS N/A
- AVNW N/A
- EPS
- GOSS N/A
- AVNW N/A
- Revenue
- GOSS $114,701,000.00
- AVNW $435,926,000.00
- Revenue This Year
- GOSS N/A
- AVNW $8.97
- Revenue Next Year
- GOSS $172.31
- AVNW $6.53
- P/E Ratio
- GOSS N/A
- AVNW N/A
- Revenue Growth
- GOSS N/A
- AVNW 14.58
- 52 Week Low
- GOSS $0.50
- AVNW $12.96
- 52 Week High
- GOSS $1.55
- AVNW $32.13
- Technical
- Relative Strength Index (RSI)
- GOSS 56.55
- AVNW 68.96
- Support Level
- GOSS $1.06
- AVNW $17.32
- Resistance Level
- GOSS $1.26
- AVNW $21.89
- Average True Range (ATR)
- GOSS 0.11
- AVNW 0.85
- MACD
- GOSS 0.04
- AVNW 0.46
- Stochastic Oscillator
- GOSS 70.09
- AVNW 81.11
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.